Work with your health care provider to find out what your personal risk is and how often you should be screened. Have you had your colon cancer screening test? – March is National Colorectal Cancer Awareness Month in US. “Colon cancer can be prevented with screening and removal of any polyps before they develop into cancer” says Sheryl M. Ness, R.N., Mayo Clinic nurse educator.
FDA approves Zaltrap for metastatic colorectal cancer – The U.S. Food and Drug Administration approved Zaltrap (ziv-aflibercept) for use in combination with a FOLFIRI (folinic acid, fluorouracil and irinotecan) chemotherapy regimen to treat adults with colorectal cancer.
A recent analysis of data collected in the National CT Colonography Trial conducted by the American College of Radiology Imaging Network confirms the efficacy of the exam as a front line colorectal cancer screening tool for seniors – Computerized tomographic (CT) colonography (CTC), also known as virtual colonoscopy, is comparable to standard colonoscopy in its ability to accurately detect cancer and precancerous polyps in people ages 65 and older.
Drug improves survival of colorectal cancer patients, trial results show – Regorafenib – an investigational drug – slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer. This is the first novel agent in eight years to show improvement in overall survival of colon cancer patients who have run out of treatment options.
High fiber diet linked to reduced risk of colorectal cancer – Dietary fiber, whole grains, and risk of colorectal cancer – Eating a diet high in fibre, particularly from cereal and whole grains, is associated with a reduced risk of colorectal cancer. Intake of dietary fibre and whole grains is known to help protect against cardiovascular disease, but its association with colorectal cancer risk is less clear. And, although the idea that dietary fibre reduces the risk of colorectal cancer has been around for nearly 40 years.
Activation of Biomarker Appears Associated With Improved Survival Among Obese Patients With Colorectal Cancer – Among obese patients, activation of the protein biomarker CTNNB1 was associated with better colorectal cancer-specific survival and overall survival, whereas post-diagnosis physical activity was associated with better colorectal cancer-specific survival among patients negative for CTNNB1.
New test measures DNA methylation levels to predict colon cancer – An investigational DNA methylation test could alter the screening landscape for colorectal cancer, according to data presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held here Oct. 27-30, 2010.
Obesity or abnormal body weight related to increased mortality in colon cancer patients – Postmenopausal women diagnosed with colon cancer may be at increased risk of death if they fail to maintain a healthy body weight before cancer diagnosis, revealed by researchers.
Omega 3 curbs precancerous growths in those prone to bowel cancer — Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis – A purified form of an omega 3 cuts the number and size of precancerous bowel growths (polyps) in people whose genetic make-up predisposes them to bowel cancer, finds research published ahead of print in the journal Gut.
Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for FUSILEV(R) in Advanced Metastatic Colorectal Cancer – A Complete Response letter is issued by the U.S. Food and Drug Administration (FDA) regarding the supplemental New Drug Application (sNDA) for FUSILEV (levoleucovorin) for injection for treatment of patients with advanced metastatic colorectal cancer.